Cellular Immunotherapy for Carcinoma Using Genetically Modified EGFR-Specific T Lymphocytes

Cellular Immunotherapy for Carcinoma Using Genetically Modified EGFR-Specific T Lymphocytes

Epidermal growth factor receptor (EGFR) is overexpressed in a variety of human malignancies, including pancreatic cancer, breast cancer, colon cancer, and non-small cell lung cancer. Overexpression of EGFR is a predictive marker of therapeutic response and several lines of evidence suggest that EGF...

Full description

Bibliographic Details
Main Authors: Xikun Zhou, Jing Li, Zhen Wang, Zhongwen Chen, Ji Qiu, Yinbing Zhang, Wei Wang, Yu Ma, Nongyu Huang, Kaijun Cui, Jiong Li, Yu-quan Wei
Format: Article
Language:English
Published: Elsevier 2013-05-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558613800401

Internet

http://www.sciencedirect.com/science/article/pii/S1476558613800401

Similar Items